Comment by evandijk70
2 days ago
Lots of reasons.
The new drug could be cheaper to manufacture, fewer side effects, a full cure in stead of a functional cure.
2 days ago
Lots of reasons.
The new drug could be cheaper to manufacture, fewer side effects, a full cure in stead of a functional cure.
Cost of manufacture is not a meaningful driver of pricing outside the biological
How will your clinical trial of the ostensible full cure work if standard of care is curing people?
A full cure would probably have less side-effects, since a functional cure means a life-long dependence on drugs.